Dominik Mytzka is a PhD candidate at the Institute of Pharmacy and Molecular Biotechnology at the University of Heidelberg. As approved pharmacist he is trained in galenic and pharmacokinetic analysis of drug substances. In his work, he is developing and improving dosage forms for psychedelics and their prodrugs.